Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage

Marco Ferlini, Roberta Rossini

Research output: Contribution to journalArticle

Abstract

Left atrial appendage has been shown as a primary source of thrombi in patients with non-valvular atrial fibrillation (AF). Non vitamin k oral anticoagulants (NOAC) have been shown to be safe and effective in the prevention of embolic complications. Current guidelines on AF state that percutaneous left atrial appendage closure (LAAC) might be considered in patients with contraindication to long term oral anticoagulant therapy (OAC). An overview of the main trials on NOAC and LAAC is provided.

Original languageEnglish
Pages (from-to)42-44
Number of pages3
JournalInternational Journal of Cardiology
Volume251
DOIs
Publication statusPublished - Jan 15 2018

Keywords

  • Atrial fibrillation
  • Left atrial appendage closure
  • NOAC

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage'. Together they form a unique fingerprint.

  • Cite this